A pilot study discovered that the FSHR Ser680Asn genotype does not influence the follicular fluid hormonal profile or ovulation outcomes in cycles stimulated with varying gonadotropin preparations. The research, involving 40 women undergoing ART, compared two genetic variants and determined no significant impact on treatment results.
Read More
UFC 304 Fight Night Recap: Edwards Retains Title Against Muhammad
Njambi Koikai’s Endometriosis Battle: A Call for Enhanced Healthcare in Kenya
Suresh Gopi Clears Air on Quitting Union Ministry Rumors Amidst New Film Commitments
Reflecting on Tito Jackson’s Legacy and the Future of Gary, Indiana
High Court Intervenes in Muguka Ban Controversy in Coastal Counties
